Anika Granted Additional 510(k) for Tactoset Bone Substitute

Anika Tactoset Injectable Bone Graft Substitute

Anika Therapeutics received an additional FDA 510(k) clearance for Tactoset Injectable Bone Substitute. This new indication expands the use of Tactoset to be combined with autologous bone marrow aspirate (BMA), a source of various cellular and molecular components which have demonstrated positive effects on tissue regeneration in musculoskeletal...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us